4/15/2013

Companies with multiple pending registration submissions in Brazil will be allowed to define the order of priority in which their products should be evaluated, according to Anvisa, the country's health care products regulatory agency. The move is part of new measures recently announced by the agency to simplify and speed up the registration of medical products in Brazil.

Related Summaries